Bottom line
IDEV vs IMTM: the short answer
IDEV (iShares Core MSCI International Developed Markets ETF) and IMTM (iShares MSCI Intl Momentum Factor ETF) share a meaningful slice of their top holdings — about 64% by weight.
But IDEV is far broader, holding 2,337 positions to 319 for IMTM, so beyond the top names it adds exposure IMTM doesn't have.
IDEV is cheaper at 0.04% vs 0.3% — a difference of $26 a year per $10,000 invested.
Over five years, IMTM returned +6.7% a year vs +5.0% for IDEV.
Updated Nov 19, 2026
IDEV vs IMTM side by side
| IDEV | IMTM | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 0.04% | 0.3% |
| Annual cost per $10k | $4 | $30 |
| 10-yr cost on $10k (prospectus) | $51 | $381 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +4.5% | +12.3% |
| 5-yr return (annualized) | +5.0% | +6.7% |
| 10-yr return (annualized) | — | +6.5% |
| Best quarter | +16.9% | +19.2% |
| Worst quarter | −24.0% | −15.5% |
| Net assets (fund) | $31.6B | $4.2B |
| Number of holdings | 2,337 | 319 |
| Portfolio turnover | 3% | 109% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IDEV | IMTM | Difference |
|---|---|---|---|
| 2024 | +4.5% | +12.3% | −7.8% |
| 2023 | +17.3% | +13.7% | +3.6% |
| 2022 | −14.9% | −16.7% | +1.7% |
| 2021 | +12.7% | +6.5% | +6.2% |
| 2020 | +8.4% | +21.9% | −13.5% |
| 2019 | +23.4% | +24.5% | −1.1% |
| 2018 | −14.3% | −14.0% | −0.4% |
Source: Fund prospectus bar charts
Holdings overlap
16 of IDEV's top 25 holdings also appear in IMTM's top 25.
| Holding | IDEV | IMTM |
|---|---|---|
| ASML Holding N.V. | 2.19% | 5.18% |
| Hsbc Holdings Plc | 1.24% | 2.99% |
| Roche Holding AG | 1.05% | 1.95% |
| Royal Bank Of Canada | 1.00% | 2.45% |
| Novartis AG | 0.98% | 1.91% |
| Astrazeneca Plc | 0.88% | 1.30% |
| Shell Plc | 0.88% | 1.58% |
| Mitsubishi UFJ Financial Group, Inc. | 0.82% | 1.34% |
| Bhp Group Limited | 0.73% | 1.30% |
| Banco Santander, S.A. | 0.70% | 1.67% |
| The Toronto-dominion Bank | 0.68% | 1.92% |
| Allianz SE | 0.65% | 0.96% |
| Totalenergies Se | 0.59% | 1.73% |
| Banco Bilbao Vizcaya Argentaria, S.A. | 0.54% | 1.16% |
| Sumitomo Mitsui Financial Group, Inc. | 0.53% | 1.19% |
Source: SEC Form N-PORT
IDEV top 10
- ASML Holding N.V. — 2.19%
- Hsbc Holdings Plc — 1.24%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
- Roche Holding AG — 1.05%
- Royal Bank Of Canada — 1.00%
- Novartis AG — 0.98%
- Astrazeneca Plc — 0.88%
- Nestle S.A. — 0.88%
- Shell Plc — 0.88%
- Siemens Aktiengesellschaft — 0.83%
IMTM top 10
- ASML Holding N.V. — 5.18%
- Hsbc Holdings Plc — 2.99%
- Royal Bank Of Canada — 2.45%
- Roche Holding AG — 1.95%
- The Toronto-dominion Bank — 1.92%
- Novartis AG — 1.91%
- Totalenergies Se — 1.73%
- Banco Santander, S.A. — 1.67%
- Shell Plc — 1.58%
- Advantest Corporation — 1.47%
FAQ
What is the difference between IDEV and IMTM?
Which is cheaper, IDEV or IMTM?
Should I own both IDEV and IMTM?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.